Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03834961
Title Larotrectinib in Treating Patients With Previously Untreated TRK Fusion Solid Tumors and TRK Fusion Relapsed Acute Leukemia
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Children's Oncology Group

Advanced Solid Tumor

acute leukemia

childhood fibrosarcoma



Age Groups: child | adult
Covered Countries USA | CAN

Additional content available in CKB BOOST